Global Stem Cells Group Announces Stem Cell Training Course Scheduled in Barcelona
Global Stem Cells Group and its subsidiary Stem Cell Training, Inc., have announced plans to hold a stem cell training course in Barcelona, Spain, Nov. 11 – 12, 2016. Orthopedic and cosmetic surgeon J. Victor Garcia Gimenez, M.D. will conduct the course for qualified physicians and medical professionals.
[su_spacer]
J. Victor Garcia Gimenez, M.D.
Garcia Gimenez, a member of the Global Stem Cells Group Advisory Board, first conducted the course for GSCG in 2014. The
course is part of the Miami-based biotech company’s growth in the European market.
The training course was developed for physicians and high-level practitioners to learn clinical protocols and state-of-the-art techniques for isolating and re-integrating adipose- and bone marrow-derived stem cells. Stem cells are harvested from the patient’s own body and redistributed to areas of the body receiving treatment. Patients experience an effective, non-invasive procedure, and a faster recovery period with little to no downtime.
Garcia Gimenez is a specialist in orthopedic and cosmetic surgery, president of Therapeutic Confrontations (CONFTERA), and practices cosmetic and anti-aging medicine, as well as aesthetic therapies in Barcelona. He is the president of the Spanish Society of Medicine and Cosmetic Surgery; co-director of the UAB-SEMCC; Chairman for Spain of the International Academy of Cosmetic Surgery, in addition to other medical and professional boards.
The stem cell training course will be offered through Global Stem Cells Group affiliate Stem Cell Training, Inc.
To learn more, visit the Global Stem Cells Group website, or the Stem Cell Training website, email bnovas(at)regenestem(dot)com, or call +1 305 560 5337.
About Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
About Stem Cell Training, Inc.:
Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. The coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatment.
To view this press release live online, click here.
###
- Published in Press Releases
Global Stem Cells Group Launches Two Stem Cell Treatment Centers in Arica and Iquique, Chile
Global Stem Cells Group announces the launch of two new stem cell treatment clinics in the cities of Arica and Iquique in northern Chile. The facilities are part of the international biotech company’s expanding presence in Latin America.
MIAMI, May 31, 2016—Global Stem Cells Group, a leading international biotechnology company, announces the launch of operations at two new GSCG clinics in the cities of Arica and Iquique in northern Chile. The facilities are part of GSCG’s expanding presence in Latin America.
Both the Arica and Iquique clinics offer the most advanced protocols and techniques in stem cell medicine to patients from around the world.
The clinics are headed by stem cell specialists Victor Perez, M.D., and Duval Aguirre, M.D., and will offer treatments in chronic degenerative conditions, Type 2 diabetes, COPD, traumatology and sports medicine.
Global Stem Cells Group, has been expanding its clinical presence throughout Latin America and worldwide by partnering with qualified physicians experienced in stem cell therapies to open new clinics. The new Arica and Iquique clinics are certified for the medical tourism market.
Global Stem Cells Group is committed to the highest standards in service and technology, expert and compassionate care, and a philosophy of exceeding the expectations of their international patients.
For more information, visit the Global Stem Cells Group website, Email bnovas@stemcellsgroup.com, or call 305-560-5337.
About the Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Groups corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
To view this press release live online, click here
###
- Published in Press Releases
Gordie Howe’s Stem Cells Treatments Support a Growing Appeal for These Therapies Among Athletes and Baby Boomers
The Story of Gordie Howe’s Stem Cell Treatment
In October 2014, Gordie Howe, the legendary hockey player, faced a life-threatening stroke that left him severely debilitated. Despite medical efforts, including an experimental stem cell treatment in Mexico, his condition continued to deteriorate. However, after receiving neural and mesenchymal stem cells, Howe showed remarkable signs of improvement, including regaining mobility and cognitive function.
The Impact of Stem Cell Therapy on Gordie Howe’s Recovery
- Experimental Treatment: Howe’s treatment involved injecting neural and mesenchymal stem cells into his spinal canal, aiming for brain repair and anti-inflammatory benefits.
- Recovery Milestones: Within hours of the procedure, Howe exhibited unexpected improvements, such as walking unaided for the first time since his stroke.
Stem Cell Therapy: Appeal Among Athletes and Baby Boomers
Athletes’ Interest in Stem Cell Therapy
Athletes, prone to injuries and degenerative conditions, increasingly turn to stem cell therapy for its potential regenerative properties. Icons like Bart Starr and John Brodie have also pursued such treatments.
Growing Popularity Among Baby Boomers
The aging population, particularly baby boomers, seeks stem cell therapies to address age-related ailments such as joint degeneration and chronic conditions.
Controversies and Regulatory Challenges
Despite its appeal, stem cell therapy faces scrutiny due to regulatory issues and varying international standards. The FDA is developing guidelines to regulate these treatments, distinguishing between approved clinical trials and unauthorized clinics.
Regulatory Landscape and FDA Guidelines
- Current FDA Oversight: Most stem cell therapies require FDA approval, with exceptions for minimally manipulated cells.
- Unauthorized Clinics: Concerns persist over unauthorized stem cell clinics operating outside regulatory frameworks.
Future Directions and Considerations
As research and public interest in stem cell therapy continue to grow, ongoing debates over efficacy, safety, and regulatory oversight shape its future in medical practice.
- Published in Corporate News / Blog
